LivaNova PLC (LIVN) support and resistance · P/E 41, rev $752.8M
LivaNova PLC (LIVN) is a medical devices company listed on NASDAQ.
This page maps LivaNova PLC (LIVN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LIVN revenue for 2026-06-30 was $752.8M. Net income was $130.9M. LIVN currently screens at market cap $4.40B and trailing P/E 40.8.
LIVN currently screens at market cap $4.40B and trailing P/E 40.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LIVN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LIVN quote page for the session range and the stock page for the full model.
Not investment advice.